EMBL-Cancer Core Europe Conference: Cancer Immunotherapy


New member
May 9, 2016

Event date

2 - 4 Feb 2017


The 2017 EMBL-Cancer Core Europe Conference on Cancer Immunotherapy will cover highly relevant sub-disciplines of cancer immunology with a special focus on personalised immunotherapy.

The European Molecular Biology Laboratory (EMBL) and Cancer Core Europe - a consortium of Europe's 6 leading Comprehensive Cancer Centers (Gustave Roussy Cancer Campus Grand Paris, France; Cambridge Cancer Centre, United Kingdom; Karolinska Institutet, Sweden; Netherlands Cancer Institute (NKI), Vall d’Hebron Institute of Oncology, Spain and the German Cancer Research Centre (DKFZ) with it's National Center for Tumour Diseases (NCT) Heidelberg) - are proud to join forces to host the first EMBL-Cancer Core Europe Conference on Cancer Immunotherapy.

  • Unleashing endogenous immunity
  • Clinical studies of T cell-based immunotherapies
  • Markers of effective immune responses
  • Targeting the microenvironment
  • Inducing immunity

For more information please visit: http://www.embl.de/training/events/2017/CCE17-01/index.html